[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6212 followers
Created: 2025-07-28 08:27:16 UTC

Thyrocare’s Growth Surge: XX% Revenue Jump, 9.5K+ Franchisees & Global Expansion 🌍 | MCap XXXXXXXX Cr

- Achieved XX% YoY revenue growth in Q1 FY'26: standalone ₹179 Cr, consolidated ₹193 Cr.
- Processed 46.9M tests (+15% YoY) and served 4.6M patients (+12% YoY).
- Franchisee base grew to 9,500+ (from XXXXX in Q1 FY'25), adding ~100/month.
- Became India’s first XXX% NABL-accredited national lab chain; complaints reduced to 4/million (from 6.4).
- New tests (Jaanch +17% YoY, Her Check) fueled growth.
- Expanded labs in Roorkee, Kashmir, Bhagalpur; partnered with 192+ facilities in Tanzania (live since March 2024).
- EBITDA margin up XXX bps to 35%; PAT surged XX% YoY to ₹38.06 Cr.
- Exploring acquisitions post-successful Polo & Vimta integration.

Complete Source:

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Preview 👇 (First X out of XX pages)

![](https://pbs.twimg.com/media/Gw7lwhlXYAAUo1h.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1949748478223012293/c:line.svg)

**Related Topics**
[mcap](/topic/mcap)
[quarterly earnings](/topic/quarterly-earnings)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1949748478223012293)